A recent human intervention trial showed that daily supplementation with selenized yeast (Seyeast) led to a decrease in the overall cancer morbidity and mortality by nearly 50%; past research has also demonstrated that selenized garlic (Se-garlic) is very effective in mammary cancer chemoprevention in the rat model. The goal of this study was to compare certain biological activities of Se-garlic and Se-yeast and to elucidate the differences based on the chemical forms of selenium found in these two natural products. Characterization of organic selenium compounds in yeast (1922 µg/g Se) and garlic (296 µg/g Se) was carried out by high-performance liquid chromatography with inductively coupled plasma mass spectrometry or with electrospray mass spectrometry. Analytical speciation studies showed that the bulk of the selenium in Se-garlic and Se-yeast is in the form of γ-glutamyl-Se-methylselenocysteine (73%) and selenomethionine (85%), respectively. The above methodology has the sensitivity and capability to account for >90% of total selenium. In the rat feeding studies, supplementation of Se-garlic in the diet at different levels consistently caused a lower total tissue selenium accumulation when compared to Se-yeast. On the other hand, Se-garlic was significantly more effective in suppressing the development of premalignant lesions and the formation of adenocarcinomas in the mammary gland of carcinogen-treated rats. Given the present finding on the identity of selenomethionine and γ-glutamyl-Se-methylselenocysteine as the major form of selenium in Se-yeast and Se-garlic, respectively, the metabolism of these two compounds is discussed in an attempt to elucidate how their disposition in tissues might account for the differences in cancer chemopreventive activity.
INTRODUCTION
The most exciting news in selenium and cancer prevention research in recent years is the finding by Clark et al. (1996) that supplementation of free-living people with selenized brewer's yeast is capable of decreasing the overall cancer morbidity and mortality by nearly 50%. The study was a double-blind, randomized, placebo-controlled trial involving 1312 patients (mostly men) who were recruited initially because of a history of basal cell or squamous cell carcinoma of the skin. Individuals in the treatment arm were given 200 µg of Se per day (average daily intake in the United States is ∼100 µg) for a mean of 4.5 years. After a total follow-up of 8271 person-years, selenium treatment did not significantly affect the incidence of these nonmelanoma skin lesions. However, patients receiving the Se-yeast supplement showed a much lower prevalence of developing and dying from lung, colon, or prostate cancer (RR varied from 0.66 to 0.33). Although these beneficial effects of selenium require independent confirmation with an appropriate design, the above study demonstrated that selenium supplementation represents a safe and viable way of achieving significant cancer protection.
The intervention trial of Clark et al. (1996) is a classic example of "targeted chemoprevention" in which a particular substance is given to high-risk individuals for the purpose of reducing cancer morbidity. There is a second concept of chemoprevention which is aimed at providing cancer protective chemicals to large segments of the population who are not at an increased risk because of known exposure to carcinogens, genetic predisposition, or prior diagnosis of malignancy . This plan requires a wide distribution method, and an expeditious way of delivering these protective agents is through foods.
It is almost impossible to increase selenium intake by eating certain types of food because most common foods have a very low selenium content (Morris and Levander, 1970) . Stimulated by the knowledge that plants convert inorganic selenium in soil to organic selenium compounds following the sulfur assimilatory pathway (Shrift, 1973) , Ip and co-workers were able to enrich garlic with selenium by fertilizing the crop with water-soluble selenate and selenite salts (Ip et al., 1992) . By controlling the intensity and frequency of selenium fertilization, it is possible to cultivate Se-garlic enriched with 100-1355 µg/g Se dry weight (Ip and Lisk, 1995) . As a point of reference, natural garlic sold in the grocery stores contains <0.05 µg/g Se. After harvest and processing, the Se-garlic was lyophilized and milled to a powder for feeding to laboratory animals for characterization of its cancer chemopreventive activity (Ip and Lisk, 1994 Ip et al., 1996) .
New methodologies of high-performance liquid chromatography with inductively coupled plasma mass spectrometry (HPLC-ICP-MS) and with electrospray mass spectrometry (ESI-MS) as well as gas chromatography with atomic emission detection (GC-AED) have recently been used to characterize a variety of organic selenium compounds from natural sources at levels as low as 20 ng/mL Se (Cai et al., 1995; Ge et al., 1996; Bird et al., 1997a,b; Uden et al., 1998; Kotrebai et al., 1999; Casiot et al., 1999) . Our plan was to carry out parallel analytical and biological studies on the same batch of Se-garlic and Se-yeast so that the information from selenium-enriched foods can be integrated and interpreted in a meaningful manner.
MATERIALS AND METHODS
Se-Yeast and Se-Garlic. The high-selenium brewer's yeast was obtained from Nutrition 21, San Diego, CA. The material, which was provided in a powder form (95% through 60 mesh), contained 1922 µg/g Se on a dry weight basis. The Se-garlic, produced by inorganic selenium salt fertilization as described previously (Ip et al., 1992) , contained 296 µg/g Se. Total selenium analysis was determined by using the fluorometric method of Olson et al. (1975) or by ICP-MS (Uden et al., 1998; Kotrebai et al., 1999) .
Instrumentation. An inductively coupled plasma mass spectrometer (ICP-MS) (Elan 5000, Perkin-Elmer Sciex, Thornhill, ON, Canada) served as the detector for HPLC. Samples were introduced by a Meinhard nebulizer with a spray chamber containing an impact bead. The ICP-MS parameters were as described elsewhere (Kotrebai et al., 1999 ). The chromatographic system consisted of a pump (SP8810, Spectra-Physics, San Jose, CA) and a 5 µm Symmetry Shield RP8 column (3.9 mm × 15 cm; Waters Corp., Milford, MA). The column was connected to the nebulizer with PEEK tubing (30 cm × 0.25 mm i.d.). The mobile phase composition was 99:1 (v/v) water/methanol with 0.1% trifluoroacetic acid or 0.1% heptafluorobutanoic acid. The mobile phase flow rate was typically 1.0 mL/min, and the sample injection volume was 20 µL.
A Bruker-Hewlett-Packard Esquire-LC mass spectrometer (Bruker-Franzen Analytik GmbH, Bremen, Germany) was used for the molecular mass spectral studies. For HPLC-MS analysis, the 1 mL/min column output was split in a 1:5 ratio with a T flow splitter. The column was connected to the ESI source with PEEK tubing (8 cm × 0.25 mm i.d.). Mass calibration and optimization were performed daily.
Chemicals. Barnstead E-pure 18 Mohm water (Boston, MA), hydrochloric acid (purified by sub-boiling), trifluoroacetic acid (Aldrich, Milwaukee, WI), and methanol (HPLC grade) were used. DL-Selenomethionine and Protease XIV were obtained from Sigma (St. Louis, MO). Se-Adenosyl-DL-selenohomocysteine and γ-glutamyl-Se-methyl-L-selenocysteine were synthesized in-house (E. Block et al., unpublished data) . Stock solutions of selenoamino acids were prepared in 0.2 M HCl. All solutions were stored in the dark at 0-4°C.
Sample Preparation. The enzymatic and hot water extractions of Se-garlic and Se-yeast followed the procedures Chemistry and Biological Activity of Selenized Plants reported earlier (Uden et al., 1998) and therefore are only briefly summarized here. For the hot water extraction, 5 mL of distilled deionized water was added to 0.2 g of sample in a 15-mL centrifuge tube, and the tube was placed in a doubleboiling water bath for an hour. The mixture was shaken well every 15 min. For the enzymatic extraction, 5 mL of distilled deionized water was added to 0.2 g of sample and 0.02 g of Protease XIV enzyme in a 15-mL centrifuge tube and shaken for 24 h at room temperature. For the preparation of concentrated extracts, the original sample-to-water ratio (0.2 g/5 mL) was increased 5-fold. After the extraction, the samples were centrifuged and filtered.
Design of in Vivo Experiments in Rats. The biological activities of Se-yeast and Se-garlic were evaluated in rats with the use of three separate endpoints: tissue selenium accumulation, reduction of premalignant lesions in the mammary gland, and mammary cancer prevention bioassay. Pathogen-free female Sprague-Dawley rats were purchased from Charles River Breeding Laboratories (Wilmington, NC) at 45 days of age. They were fed the AIN-76A basal diet (Report of the American Institute of Nutrition, 1977) for several days to acclimatize them to the powder ration. This basal diet contained 0.1 µg/g Se as sodium selenite. At ∼50 days of age, the animals were entered into different experimental protocols as described below.
For the tissue selenium accumulation study, rats were given either Se-garlic or Se-yeast, supplemented to the basal diet at a final concentration of 1, 2, or 3 µg/g Se (n ) 6/group). The feeding continued for 6 weeks, at which point the animals were sacrificed. Liver, kidney, mammary gland, skeletal muscle, and plasma were collected at necropsy. The samples were frozen immediately in liquid nitrogen and stored at -80 °C until ready for analysis of total selenium (Olson et al., 1975) .
For the mammary gland premalignant lesion study, rats were injected i.p. with methylnitrosourea (MNU) at a dose of 50 mg/kg of body weight. Immediately after carcinogen administration, animals were divided into three groups (n ) 6 rats/group): control (fed basal diet containing 0.1 µg/g Se), Segarlic (at 3 µg/g Se), and Se-yeast (at 3 µg/g Se). Animals were sacrificed at 6 weeks after selenium supplementation. The abdominal-inguinal mammary gland chain was excised in one piece, fixed in 10% buffered formalin, and processed in a Tissue-Tek vacuum infiltration processor. After processing, it was divided into six segments and embedded in paraffin blocks. Ribbons of 5-µm thickness were cut from each block and placed on slides that had been treated with 3-aminopropyltriethoxysilane. Every 10th section was heat immobilized, deparaffinized in xylene, rehydrated in descending grades of ethanol, and stained with hematoxylin and eosin. These H&E slides were examined under the microscope for the appearance of premalignant intraductal proliferation (IDP) lesions using the criteria delineated by Russo et al. (1982) . Once an IDP lesion was found, the in-between slides were similarly stained to confirm the histology. The size of each lesion could thus be estimated operationally by the number of serial sections showing the pathology. The total IDP count data were analyzed by the chi square test using the Poisson regression model (McCullagh and Nelder, 1989) .
Two mammary cancer prevention bioassays were carried out, one with the MNU model and the other with the dimethylbenz[a]anthracene (DMBA) model. Rats in each experiment were given a dose of MNU (50 mg/kg of body wt) i.p. or DMBA (50 mg/kg of body wt) i.g. at ∼50 days of age for the induction of mammary tumors. They were then fed the Segarlic-or Se-yeast-containing diet at a level of 3 µg/g Se. Control rats continued to receive the basal diet containing 0.1 µg/g Se. All animals were palpated for mammary gland tumors once a week. The experiment was continued for 24 weeks before termination. By this time, the development of palpable tumors had plateaued for several weeks across all groups. At necropsy, all tumors were excised and fixed for histological evaluation. Only confirmed adenocarcinomas are reported in the results. Tumor incidences at the final time point were compared by chi-square analysis, and the total tumor yield was compared by frequency distribution analysis as described previously (Horvath and Ip, 1983) .
RESULTS

HPLC-ICP-MS Analysis.
On-line HPLC-ICP-MS chromatograms, using 0.1% trifluoroacetic acid as ionpairing agent, of enzymatic extract of Se-yeast and water extract of Se-garlic are shown in parts a and b, respectively, of Figure 1 (0.2 g/5 mL of sample extract). The identities of the peaks eluting at 3.08 and 6.21 min (Figure 1a ) and at 4.95 min (Figure 1b) were first established by spiking the samples with the appropriate standards. The peaks were identified as selenomethionine, Se-adenosylselenohomocysteine, and γ-glutamyl-Se-methylselenocysteine, respectively. The peak at 11.45 min ( Figure 1b ) could not be matched by retention time against any available standard.
Comparison of a yeast water extract (not shown) with Figure 1a showed the absence of the major selenomethionine peak, suggesting that it is immobilized, perhaps in proteins; Se-adenosylselenohomocysteine appeared as the major selenium compound. The extraction efficiency and column recovery values of selenium for the enzymatic extracts of yeast were 80-90%, whereas the hot water extraction efficiency was only ∼10% (Uden et al., 1998; Kotrebai et al., 1999) . The two identified compounds account for ∼82% of the total selenium in compounds eluting from the enzymatic extract. Comparison of the garlic powder's water extract with its enzymatic extract ( Figure 1b ) shows no major difference in the γ-glutamyl-Se-methylselenocysteine peak areas, indicating that it is not immobilized into proteins. As observed in the case of yeast, selenomethionine (peak at 3.1 min) was effectively extracted only by the enzymatic process. For garlic powder, the hot water extraction column recovery values were 80-90%, γ-glutamyl-Se-methylselenocysteine accounting for 85% of the total selenium compounds eluted. With enzymatic extraction, the efficiency approached 100%, with selenomethionine and γ-glutamyl-Se-methylselenocysteine together accounting for ∼86% of the total selenium species eluted.
The separation achieved by the use of trifluoroacetic acid (Figure 1a ,b) was not of adequate resolution to identify the early eluting peaks in the chromatogram. To identify the compounds in that region, heptafluorobutanoic acid, a much stronger ion-pairing agent, was used. This separation is demonstrated in Figure 2 . The identifications of (a) selenate, (b) selenite, (c) selenolanthionine, (d) selenocystine, (e) selenocystathionine, and (f) Se-methylselenocysteine were made by spiking the samples with the appropriate standards. As noted above, the extraction efficiency from yeast was estimated to be between 80 and 90% based on total selenium content, whereas that from garlic was close to 100% on the same basis. The independence of ICP-MS response for selenium-82 with respect to molecular structure enables total chromatographic peak area measurements to be used for these calculations with confidence. The percentage composition of the selenium content eluted from the column, taking into account the foregoing extraction efficiency, is reported in Table 1 .
HPLC-ESI-MS Analysis. All analyses were carried out on-line, to preclude sample decomposition during the preconcentration procedure. Figure 3 shows the overlaid single ion chromatograms (SIC) of selenom-ethionine (3.41 min), γ-glutamyl-Se-methylselenocysteine (5.07 min), and Se-adenosylselenohomocysteine (6.39 min) at selenium concentrations of 50, 20, and 10 µg/mL, respectively. Separate chromatograms were run to obtain the best combination of response and peak shapes for the different levels of selenium in the three components. The selenomethionine has a molecular ion M + 1 at 198 with a loss of 17, which is attributed to ammonia, producing a fragment ion at m/z 181. The M + 1 values for γ-glutamyl-Se-methylselenocysteine and Se-adenosylselenohomocysteine are 313 and 433, respectively. The distinctive selenium isotopic pattern [ 74 Se (1%), 76 Se (9%), 77 Se (8%), 78 Se (24%), 80 Se (50%), 82 Se (9%)] is clearly seen in each case.
The SIC of m/z 313 (5.11 min) and m/z 327 (10.12 min) from "dilute" (0.2 g/5 mL) and "concentrated" (1 g/5 mL) hot water extracts of garlic, respectively, are shown in Figure 4 . The "concentrated" extracts showed a retention time decrease as seen for Figure 2 (11.45 min) and Figure 4 (10.12 min) for the same compound, due to a Percentage sum is based on total eluted selenium by HPLC-ICP-MS, calculated from peak area measured at 82 Se.
overloading of the column. The same effect was seen when the injection volume of the dilute extract was increased 5-fold from 20 to 100 µL. The mass spectrum of the 5.11 min peak confirms the identification of this peak as γ-glutamyl-Se-methylselenocysteine. The peak at 10.12 min was tentatively identified as γ-glutamylselenomethionine on the basis of its molecular weight, the region where it elutes, and the fact that γ-glutamylmethionine occurs in garlic (Virtanen, 1965; Koch and Lawson, 1996) , but a standard to confirm its retention time is not yet available.
The SIC of m/z 198 (3.14 min) and m/z 433 (6.31 min) from the dilute enzymatic extract of Se-yeast appears in Figure 5 . A similar mass spectrum is obtained for the peak eluting at 6.3 min from the hot water extract of the same sample. The mass spectra of the peaks at 3.14 and 6.31 min confirm their identity as selenomethionine and Se-adenosylselenohomocysteine, respec- tively, reinforcing the off-line identification of Se-adenosylselenohomocysteine in the water extract of Seyeast (Casiot et al., 1999) . The additional noted ions appearing in these spectra in comparison with the HPLC of the reference compounds in Figure 3 are due to non-selenium-containing species coeluting or overlapping with the target analytes. These give rise to ESI-MS spectra but are, of course, not seen in selenium selective HPLC-ICP-MS.
Evaluation of Biological Activities. Table 2 shows the data of total selenium accumulation in tissues of rats fed either Se-garlic or Se-yeast. Both supplements produced a dose-dependent elevation in selenium levels in all tissues examined. However, in every case, Se-yeast caused a significantly higher increase in total selenium as compared to Se-garlic when either one was supplemented in the range of 1-3 µg/g dietary selenium. For example, at the 3 µg/g Se dose, the concentrations of selenium in liver, kidney, mammary gland, skeletal muscle, and plasma were 54, 57, 51, 53, and 31% less, respectively, in rats fed Se-garlic than in those fed Seyeast. Thus, it is clear that Se-garlic at chemopreventive levels of intake results in only a modest change in tissue selenium.
The pathobiology of chemical carcinogenesis in the rat mammary gland has been well elucidated by the team of Russo and Russo (1982) . Their work provided evidence that the terminal end buds are the primary sites for the induction of mammary carcinomas. Within 2-3 weeks after carcinogen dosing, enlargement of the terminal end bud, due to a localized piling up of intraductal cells, is detectable in histological sections. These transformed cells continue to proliferate until they gradually fill up the lumen of the duct. These premalignant "intraductal proliferations", or IDPs, are the precursors for the eventual development of palpable carcinomas. The total count of these IDP lesions in the abdominalinguinal mammary gland chain was quantified as described under Materials and Methods. The size of each lesion was also determined operationally by the number of serial sections showing the same pathology. Table 3 shows the IDP lesion results from MNUtreated rats that were fed either Se-garlic or Se-yeast. The histology of the mammary gland sections was evaluated at 6 weeks after carcinogen administration. There were 40 IDPs found in a total of 6 rats in the control group, 17 in the Se-garlic group, and 29 in the Se-yeast group. These values are all significantly different from each other (refer to footnote of Table 3 for statistical comparisons). The lesions were categorized into four size classes with each containing e10, 11-20, 21-30, or 31-40 serial sections. To analyze the size class data, a repeated-measures option was added to the Poisson regression because most animals presented lesions in more than one size class. No significant differences were found by treatment within a size class, probably because of the much lower sample number in each category once the data were segregated. Nonetheless, it can be seen that, especially in the Se-garlic group, the reduction in IDP number was more prevalent in the larger-sized lesions. For example, there were only 7 lesions of >21 sections in the Se-garlic group as compared to 16 in the Se-yeast group and 24 in the control. The data suggest that (i) selenium chemoprevention is expressed at an early stage of carcinogenesis and (ii) Se-garlic is more active than Se-yeast in suppressing the clonal expansion of these early lesions.
The experiments evaluating the mammary cancer prevention efficacies of Se-garlic and Se-yeast are presented in Table 4 . Both supplements were started immediately after administration of either DMBA or MNU and continued until termination of the study. The data showed the change in tumor incidence and total tumor number as the endpoint. On the basis of these two parameters, our results indicated that Se-garlic was more effective than Se-yeast in mammary cancer protection in both the DMBA and MNU models. The last column of Table 4 shows the percent inhibition calculated from the tumor yield data; Se-garlic produced 66 and 70% inhibition in the DMBA and MNU experiments, in contrast to only 34 and 31% inhibition for Seyeast.
DISCUSSION
In the present study, we found that Se-yeast was only half as active as Se-garlic in our mammary cancer chemoprevention studies, despite the fact that there was a much higher total tissue selenium accumulation with Se-yeast than with Se-garlic. Analytical speciation studies showed that the bulk of the selenium in Se-garlic and Se-yeast is in the form of γ-glutamyl-Se-methylselenocysteine and selenomethionine, respectively. This is the first time >90% of the chemical form of selenium was identified and accounted for in a selenium-enriched natural product. We will discuss the interdependence of biology and chemistry in selenium chemoprevention on the basis of the knowledge gained from our past research.
We recently reported that a 1355 µg/g Se garlic sample contains Se-methylselenocysteine as the major form of selenium (Cai et al., 1995; Bird et al., 1997a) , in contrast to the present finding of γ-glutamyl-Semethylselenocysteine as the predominant compound in a 296 µg/g Se garlic sample. Our additional studies indicate that garlic samples containing <300 µg/g Se all produce the γ-glutamyl derivative as a major storage form for selenium. Both γ-glutamyl-Se-methylselenocysteine and Se-methylselenocysteine were previously identified in Astragalus bisulcatus (Nigan and McConnell, 1969) . Furthermore, γ-glutamyl-S-alk(en)ylcysteines are well-known sulfur storage compounds in garlic (Virtanen, 1965; Koch and Lawson, 1996; Block, 1992) . Interestingly, some earlier experiments by Ip and Lisk (1995) demonstrated that the anticarcinogenic effect of Se-garlic is unlikely to be affected by the degree of selenium enrichment in the garlic sample. Furthermore, the highly enriched and moderately enriched Segarlic produced similar increases in tissue selenium provided that the total intake of selenium was the same. Given what we know now about the forms of selenium in the 1355 and 296 µg/g Se garlic samples, it would be reasonable to assume that γ-glutamyl-Se-methylselenocysteine serves mainly as a carrier of Se-methylselenocysteine. Following ingestion as a dietary constituent, γ-glutamyl-Se-methylselenocysteine ( Figure 6 ) is likely to be hydrolyzed by a transpeptidase in the gastrointestinal tract, releasing Se-methylselenocysteine for absorption and systemic delivery to other tissues. We plan to use pure γ-glutamyl-Se-methylselenocysteine in our future experiments to examine the pharmacokinetics of selenium accumulation and the metabolic disposition of selenium from this molecule.
As shown in Figure 7 , Se-methylselenocysteine is metabolized in vivo by a -lyase enzyme to methylselenol (Foster et al., 1986; Ganther and Lawrence, 1997) . This enzyme is present in a number of tissues including liver, kidney, mammary gland, and intestine (Ip et al., 1999) . On the basis of our past research experience, any precursor that will generate methylselenol (or a related monomethylated selenium intermediate) via a similar reaction is more active than selenite or selenomethionine in tumor inhibition (Ganther and Lawrence, 1997; Ip and Ganther, 1992; Ip, 1998) . Thus, the facile endogenous production of monomethylated selenium is a critical factor in selenium chemoprevention. This may explain the superior activity of Se-garlic compared to Se-yeast, because the latter delivers predominantly selenomethionine.
The structures of Se-methylselenocysteine and selenomethionine are very similar to each other ( Figure 6 ). Their respective molecular weights are 182 and 196, the difference being accounted for by an additional methylene carbon in selenomethionine. Despite the similarity in chemical structure, these two selenoamino acids are metabolized very differently (Figure 7) . Selenomethionine is known to be incorporated nonspecifically into tissue proteins in place of methionine during protein synthesis, whereas this is not true for Se-methylselenocysteine (Sunde, 1990) . Total body burden of selenium is therefore consistently higher in rats fed selenomethionine compared to those fed other forms of selenium (McAdam and Levander, 1987; Whanger and Butler, 1988; Ip and Hayes, 1989) . Due to its compartmentalization into tissue proteins, selenomethionine is not as readily available as Se-methylselenocysteine for further metabolism. As noted above, the efficiency of a selenoamino acid in entering the methylation pathway of selenium metabolism is important in selenium chemoprevention (Ganther and Lawrence, 1997; Ip and Ganther, 1992; Ip, 1998) . In contrast to the -lyase-mediated reaction converting Se-methylselenocysteine to methylselenol, selenomethionine is metabolized via the multistep transselenization mechanism to selenocysteine analogous to the methionine transsulfuration mechanism. Selenocysteine, in turn, is degraded to hydrogen selenide before entering the methylation pathway (Ip and Ganther, 1992) . The slower rate of generating monomethylated metabolite from selenomethionine may also in part account for its lower anticarcinogenic activity. A relationship between selenium source and biological activity has also been described by Finley (1998) . He found that selenium from high-Se broccoli was less effective in repleting peroxidase activity than selenium from selenite, selenate, or selenomethionine. Furthermore, more selenium from broccoli was excreted in urine of rats than selenium from selenomethionine.
Because the appearance of IDP lesions precedes the development of adenocarcinomas in the mammary gland, their quantitative reduction by selenium treatment suggests that the primary action of selenium is to inhibit clonal expansion of the carcinogen-initiated cells at an early stage of the disease process. It should be pointed out that, in this study, the size of these lesions is defined operationally by the number of serial histologic sections containing the pathology. Our data indicated that Se-garlic is more potent in suppressing the growth of these premalignant lesions. This finding implies that different selenium compounds may have Chemistry and Biological Activity of Selenized Plants different efficacies in regulating the proliferation and/ or apoptosis of the early transformed cells. These research questions are presently under investigation.
The purpose of this paper is not to make recommendation of one selenium-enriched product over another for human use. The biological experiments reported here were conducted in a particular animal model, which has its own share of limitations and confounders. The application of the present sophisticated analytical instrumentation and methodology for selenium speciation has enabled a more informative and coherent approach to be followed than formerly was available to such investigations. The Clark (1996) trial has offered a glimmer of encouragement that significant cancer prevention can be achieved by selenium supplementation. We hope to add to this research database by underscoring that chemistry and biology should go hand in hand in our continuing effort to develop new strategies for selenium intervention of cancer. ABBREVIATIONS USED HPLC, high-performance liquid chromatography; ICP, inductively coupled plasma; MS, mass spectrometry; ESI, electrospray; SIC, single ion chromatogram; IDP, intraductal proliferation lesion; MNU, methylnitrosourea; DMBA, dimethylbenz[a]anthracene.
